Business Context and Reporting Period
This Form 6-K filing by Novo Nordisk A/S, dated February 20, 2026, serves as a notice for the Annual General Meeting (AGM) scheduled for March 26, 2026. The company is a leading global healthcare firm headquartered in Denmark, employing approximately 68,800 people across 80 countries and marketing products in around 170 countries. Its primary focus remains on defeating serious chronic diseases, built upon a heritage in diabetes care.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses on upcoming corporate governance events rather than financial performance comparisons.
Guidance, Outlook, and Corporate Governance
- Annual General Meeting: Scheduled for Thursday, March 26, 2026, at 14:00 CET. It will be held as a combined physical and virtual meeting at the Bella Center in Copenhagen, with a live webcast available.
- Board of Directors Proposals:
- Re-election: Lars Rebien Sørensen (Chair), Cees de Jong (Vice Chair), Britt Meelby Jensen, Stephan Engels, and Kasim Kutay.
- New Members: Helena Saxon, Jan van de Winkel, and Ramona Sequeira.
- Shareholder Participation: Shareholders are encouraged to submit proxies or votes by correspondence in advance. Participation options include in-person attendance or virtual access via PC or mobile device.
Key Facts for Investor Verification
- Verify the date and time of the Annual General Meeting: March 26, 2026, at 14:00 CET.
- Confirm the proposed slate of Board of Directors, including three new nominees.
- Check the enclosed meeting notice for specific registration requirements for physical or virtual attendance.
- Note that this filing contains no financial results; investors should refer to the company's Form 20-F or quarterly reports for financial data.